Neuropathix
Charles L. Loprinzi, M.D., is a medical oncologist whose primary research interest for more than 30 years has related to symptom control clinical trials — trials devoted to the prevention, treatment, or better understanding of untoward symptoms related to cancer, cancer treatment or both.
This person is not in the org chart
This person is not in any offices
Neuropathix
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline pain management therapeutics.